Skip to main content
Clinical Trials/JPRN-UMIN000047509
JPRN-UMIN000047509
Recruiting
未知

Evaluation using FAPI-PET targeting cancer-associated fibroblasts - Evaluation using FAPI-PET

Osaka University0 sites100 target enrollmentMay 1, 2022
ConditionsCancer

Overview

Phase
未知
Intervention
Not specified
Conditions
Cancer
Sponsor
Osaka University
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2022
End Date
March 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Pregnant women or patients who may be pregnant (2\) Pediatric patients requiring sedation (3\) Those who are judged to be inappropriate as subjects.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Pathophysiological assessment by FAPI-PET targeting cancer-associated fibroblasts in proton therapyCancer
JPRN-UMIN000052534Southern Tohoku Research Institute for Neuroscience80
Recruiting
Not Applicable
Evaluation Using FAPI-PET Targeting Cancer-associated FibroblastsNeoplasms
NCT05442151Tadashi Watabe200
Active, not recruiting
Phase 1
PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with progressive pulmonary fibrosis.Progressive Pulmonary Fibrosis (PPF)MedDRA version: 21.0Level: PTClassification code: 10037383Term: Pulmonary fibrosis Class: 100000004855Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
CTIS2023-503686-26-00St Antonius Hospital20
Recruiting
Not Applicable
FAPI-PET for Tumor DetectionMalignant Neoplasm
NCT04571086University Hospital, Essen500
Active, not recruiting
Phase 1
Role of [68Ga]Ga-FAPI PET/CT in oncological patients with doubtful or inconclusive findings at [18F]F-FDG PET/CToncological disease suspicion/ new diagnosis or with a previously treated tumour, with an inconclusive or equivocal findings after the standard clinical/diagnostic flow chart: [18F]F-FDG PET/CT imaging not able to solve the clinical doubtMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2020-005549-17-ITAOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI200